Teleflex (NYSE:TFX) announced today that it released its new Arrow pressure injectable midline portfolio of catheters in North America. Wayne, Pennsylvania-based Teleflex designed its Arrow portfolio to help alleviate line identification confusion. The company said a lack of identification between midlines and catheters creates the potential for … [Read more...] about Teleflex launches new injectable midline catheter portfolio
FDA approves Medtronic drug-eluting stents for treating bifurcation lesions
Medtronic (NYSE:MDT) announced today that the FDA approved its Onyx drug-eluting stents (DES) for treating certain lesions. Approval covers the treatment of non-left main bifurcation lesions utilizing the provisional bifurcation stenting technique. The technique uses a single stent to treat the bifurcation in percutaneous coronary interventions … [Read more...] about FDA approves Medtronic drug-eluting stents for treating bifurcation lesions
Getinge partners with Medtronic to make Radiant balloon-expandable covered stent
Getinge today announced a partnership with Medtronic (NYSE:MDT) over the Radiant balloon-expandable stent, which received CE mark. Radiant is designed for use in chimney endovascular aneurysm repair (ChEVAR) with the Endurant II/IIs stent graft system. It maintains perfusion to renal arteries when used in combination with the stent graft. The … [Read more...] about Getinge partners with Medtronic to make Radiant balloon-expandable covered stent
Advanced NanoTherapies wins FDA breakthrough nod for drug-coated balloon
Advanced NanoTherapies announced today that it received FDA breakthrough device designation for its SirPlux Duo drug-coated balloon (DCB). Los Gatos, California-based Advanced NanoTherapies received the breakthrough nod for the use of the DCB in treating coronary artery disease in vessels less than 3.0mm. The regulatory win comes weeks after two … [Read more...] about Advanced NanoTherapies wins FDA breakthrough nod for drug-coated balloon
Merit Medical launches new Prelude Roadster guide sheath
Merit Medical Systems (Nasdaq:MMSI) announced today that it commercially released its Prelude Roadster guide sheath. South Jordan, Utah-based Merit designed its Prelude Roadster for deliverability, visibility, and resilience in tortuous peripheral vasculature anatomies. It helps to deliver devices used to diagnose and treat patients with … [Read more...] about Merit Medical launches new Prelude Roadster guide sheath
Penumbra launches RED reperfusion catheters in Europe
Penumbra (NYSE:PEN) announced today that it received the CE mark for its Penumbra RED reperfusion catheter and began the European launch. Alameda, California-based Penumbra designed its RED reperfusion catheter for the removal of all clot types in acute ischemic stroke (AIS) patients. The catheters are part of the Penumbra System — a fully … [Read more...] about Penumbra launches RED reperfusion catheters in Europe
J&J’s Biosense Webster launches mapping catheter for cardiac arrhythmias
Johnson & Johnson's Biosense Webster announced today that it launched the Octaray mapping catheter with TRUEref technology. Irvine, California-based Biosense Webster designed Octaray for mapping cardiac arrhythmias, including AFib. It is powered by the company's Carto 3 Version 7 system. The catheter has eight splines with improved … [Read more...] about J&J’s Biosense Webster launches mapping catheter for cardiac arrhythmias
Data backs Penumbra’s catheters for stroke care
Penumbra (NYSE:PEN) announced today that initial data support the use of its RED reperfusion catheters and the Penumbra System. Alameda, California-based Penumbra presented results from the initial Insight Registry for the RED reperfusion catheters and the sub-analyses of the Complete study for the Penumbra system at the 2022 World Federation of … [Read more...] about Data backs Penumbra’s catheters for stroke care
FDA approves Biotronik’s self-expanding stent system
Biotronik announced today that it received FDA approval for its Pulsar-18 T3 peripheral self-expanding stent system. Pulsar-18 T3 combines a 4-French low-profile delivery system with a tri-axial system with a braided shaft design and thin struts with low chronic outward force (COF), creating an improved implantation procedure for endovascular … [Read more...] about FDA approves Biotronik’s self-expanding stent system
Stereotaxis submits robotically navigated ablation catheter for CE mark
Stereotaxis (NYSE:STXS) announced today that it submitted its MAGiC catheter for CE mark approval in Europe. The St. Louis-based company designed MAGiC as a robotically navigated, magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. Used in conjunction with Stereotaxis' robotic systems, the catheter … [Read more...] about Stereotaxis submits robotically navigated ablation catheter for CE mark